EditorialPublished 30 Sep 2024
Precision Dosing in Oncology: Exploring Pharmacokinetics of Next-Generation Therapeutics
Department of Pediatric Hematology/ Oncology and Bone Marrow Transplant Unit, University of Child Health Sciences, Pakistan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Precision dosing in oncology represents a transformative approach in cancer treatment, tailored to maximize therapeutic efficacy while minimizing adverse effects. This approach is particularly relevant in the context of nextgeneration therapeutics, including targeted therapies and immunotherapies, which exhibit complex pharmacokinetic (PK) profiles. Understanding the intricate dynamics of drug absorption, distribution, metabolism, and excretion is critical for optimizing dosing regimens. This review explores the pharmacokinetics of emerging oncological agents, emphasizing the role of PK modeling and simulations in predicting optimal dosing strategies. The integration of patientspecific factors such as genetic variations, organ function, and drug-drug interactions is discussed, highlighting its impact on personalized treatment plans. Advances in precision dosing methodologies, including the use of biomarkers and real-time therapeutic drug monitoring, are evaluated for their potential to enhance clinical outcomes. The challenges and future directions in implementing precision dosing in clinical practice are also addressed, with a focus on improving therapeutic indices and reducing toxicity in cancer patients
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Pharmacology & Biopharmaceutics
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Roelie Zafar”